Discerning malignancy in resected adrenocortical neoplasms

Endocrine Pathology

Volumn 12, Issue 4, 2001, Pages 397-406

  Sasano, Hironobu ^a   Suzuki, Takashi ^a   Moriya, Takuya ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenoma; Adrenal; Carcinoma; Cortex; Differential diagnosis; Pathology

Indexed keywords

CELL NUCLEUS ANTIGEN; GROWTH FACTOR; KI 67 ANTIGEN;

ADENOMA; ADRENAL CORTEX TUMOR; ARTICLE; BLEEDING; CARCINOMA; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DNA CONTENT; GERM LINE; HETEROZYGOSITY LOSS; IMMUNOHISTOCHEMISTRY; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR NECROSIS;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM INVASIVENESS;

EID: 0035728745     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:12:4:397     Document Type: Article

References (46)

1. Adrenocortical neoplasms: Prognosis and morphology
2. Morphologic characteristics of benign and malignant adrenocortical tumors
3. A small adrenocortical carcinoma with aggressive behavior: An evaluation of criteria for malignancy
4. Prognostic factors in adrenal cortex tumors: A mathematical analysis of clinical and morphological data
5. Myxoid neoplasms of the adrenal cortex: A rare histologic variant
6. Comparable histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
7. Pathologic features of prognostic significance in adrenocortical carcinoma
8. Adrenocortical oncocytoma: A true nonfunctioning adrenocortical tumor
9. Flow cytometric analysis of nuclear DNA from adrenocortical neoplasms: A retrospective study using paraffin-embedded tissue
10. Discerning malignancy in human adrenocortical neoplasms: Utility of DNA flow cytometry and immunohistochemistry
11. Cellular DNA profiles of benign and malignant adrenocortical tumors
12. Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia: A study of a Brazilian population
13. Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma
14. Flow cytometric study of adrenal cortical carcinoma
15. New concepts in the diagnosis and prognosis of endometrial carcinoma
16. Immunohistochemical assessment of proliferative activity in adrenal cortical neoplasms
17. DNA topoisomerase IIα and Ki-67 in human adrenocortical neoplasms: A possible marker of differentiation between adenomas and carcinomas
18. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization
19. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: High IGF-II expression in functional adrenocortical carcinomas
20. Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors: An immunohistochemical study of 94 cases
21. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours
22. Anti-alpha-inhibin: Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration
23. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm
24. Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly
25. Complexe malformatif familial avec hernie ombilicale et macroglossie: Un "syndrome nouveau"?
26. Wilms' tumor and adrenocortical carcinoma with hemihypertrophy and hamartomas
27. Generation of homozygosity at the c-Ha-ras-I locus on chromosome 11p in an adrenal adenoma from an adult with Wiedemann-Beckwith syndrome
28. Genetics of Beckwith-Wiedemann syndrome-associated tumors: Common genetic pathways
29. Prospective study of a family cancer syndrome
30. The sarcoma, breast cancer, lung cancer, and adrenocortical carcinoma syndrome revisited
31. Genetic changes in human adrenocortical carcinomas
32. Chromosomal aberrations in two adrenocortical tumors, one with a rearrangement at 11p15
33. Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications
34. Analysis of genomic alterations in sporadic adrenocortical lesions: Gain of chromosome 17 is an early event in adrenocortical tumorigenesis
35. Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3,9 and X at the adenoma stage
36. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: A review
37. Detection of novel germline p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma
38. Single base pair germ-line deletion in the p53 gene in a cancer predisposed family
39. High frequency of germline p53 mutations in childhood adrenocortical cancer
40. p53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies
41. Expression of p53 in adrenocortical tumours: Clinicopathological correlations
42. MEN1 gene mutation analysis of sporadic adrenocortical lesions
43. MEN1 gene analysis in sporadic adrenocortical neoplasms
44. Expression of cell cycle inhibitor p27 and Ki67 in human adrenocortical neoplasms
45. Telomerase activity as an indicator of potentially malignant adrenal tumors